MIRZA ZIAD 4
4 · INNOVUS PHARMACEUTICALS, INC. · Filed Jan 7, 2020
Insider Transaction Report
Form 4
MIRZA ZIAD
Director
Transactions
- Award
Restricted Stock Units
2020-01-02$0.89/sh+6,742$6,000→ 38,104 totalFrom: 2020-01-02Exp: 2030-01-02→ Common Stock (6,742 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on January 2, 2020 of 6,742 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2019 and was valued on December 31, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan.